Veranova’s expert article is a good reminder of this and worth sharing here!
The importance of chirality in API development – Veronova
The ability to reliably deliver enantiopure APIs affects everything from regulatory timelines to patient safety and market competitiveness.
As the article points out, techniques like crystallization, diastereomeric salt formation, and chiral chromatography each have strengths but also practical challenges (time, cost, scalability, solid-state unpredictability).
This is precisely where hashtag#Enantios could add value for CDMOs CROs and pharma partners.
By integrating a fast, robust enantiomeric characterization method into the development workflow, it could:
- accelerate development timelines
- de-risk scale-up by reducing dependency on complex crystallization steps
- strengthen analytical packages for regulatory submissions
- improve efficiencies across both R&D and manufacturing
In a landscape where stereochemical precision can drive competitive advantages, adding complementary tools to the chirality chain is an opportunity worth exploring.
Get in touch to know more!
contact@enantios.com
